Latest Clopidogrel Stories
DALLAS, April 22, 2015 /PRNewswire/ -- DeepResearchReports.com have "2015 Market Report on Global Clopidogrel Bisulfate Industry" added to its research database.
Emergency Department-Based Observational Study Aims to Fill Data Gaps in ACS Care Shrewsbury, NJ (PRWEB) October 27, 2014 The Hospital Quality Foundation
MarketOptimizer.org adds new report "Cangrelor (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023" to its store.
DALLAS, September 7, 2014 /PRNewswire/ -- MarketOptimizer.org adds "Acute Coronary Syndrome - US Drug Forecast and Market Analysis to 2023", a new research report to its
Researchers have identified the first genetic variations linked to race that begin to explain a higher risk of death among some African American and Caucasian patients taking the anti-clotting drug clopidogrel (Plavix) after a heart attack.
Branded Products That Improve Hospital-Based Outcomes Have Advantages in Securing Preferred Drug Status in ACOs, According to Findings from Decision Resources Group BURLINGTON, Mass., May 21,
OTTAWA, May 6, 2014 /CNW/ - Health Canada today released the April 2014 issue of the Canadian Adverse Reaction Newsletter (CARN). This issue features an article on the risk
- A person in a secondary role, specifically the second most important character (after the protagonist).